Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,882
archived clinical trials in
Obesity Weight Loss

Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Cleveland, OH
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Columbus, OH
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Mogadore, OH
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
mi
from
Mogadore, OH
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Yukon, OK
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Yukon, OK
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Bensalem, PA
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Bensalem, PA
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Cranston, RI
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Cranston, RI
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Greenville, SC
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Mount Pleasant, SC
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Bristol, TN
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Bristol, TN
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Burns, TN
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
mi
from
Burns, TN
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Knoxville, TN
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Nashville, TN
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Houston, TX
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Jackson, TX
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Jackson, TX
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
New Braunfels, TX
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
San Antonio, TX
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
West Jordan, UT
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Richmond, VA
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Renton, WA
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Green Bay, WI
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Green Bay, WI
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
mi
from
Wauwatosa, WI
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
mi
from
Ann Arbor, MI
Michigan Clincal Research Unit
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain
Status: Enrolling
Updated:  4/30/2018
mi
from
Lawrence, KA
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain
Status: Enrolling
Updated: 4/30/2018
University of Kansas - Robinson Hall
mi
from
Lawrence, KA
Click here to add this to my saved trials
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated:  4/30/2018
mi
from
Minneapolis, MN
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated: 4/30/2018
University of Minnesota, School of Nursing
mi
from
Minneapolis, MN
Click here to add this to my saved trials
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated:  4/30/2018
mi
from
Amherst, MA
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated: 4/30/2018
University of Massachusetts Amherst
mi
from
Amherst, MA
Click here to add this to my saved trials
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated:  4/30/2018
mi
from
Philadelphia, PA
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated: 4/30/2018
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
mi
from
Honolulu, HI
Department of Native Hawaiian Health, University of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment
Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment
Status: Enrolling
Updated:  4/30/2018
mi
from
Burlington, VT
Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment
Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment
Status: Enrolling
Updated: 4/30/2018
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
A Phase Ia, Randomized, Blinded, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous BFKB8488A in Otherwise Healthy Overweight and Obese Volunteers With Likely Insulin Resistance
Status: Enrolling
Updated:  4/30/2018
mi
from
Chula Vista, CA
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
A Phase Ia, Randomized, Blinded, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous BFKB8488A in Otherwise Healthy Overweight and Obese Volunteers With Likely Insulin Resistance
Status: Enrolling
Updated: 4/30/2018
Profil Institute for Clinical Research
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Resistance Exercise and Muscle Protein Synthesis in Obese Adults
Resistance Exercise as a Strategy to Enhance Postprandial Muscle Protein Synthesis in Obese Adults
Status: Enrolling
Updated:  4/30/2018
mi
from
Urbana, IL
Resistance Exercise and Muscle Protein Synthesis in Obese Adults
Resistance Exercise as a Strategy to Enhance Postprandial Muscle Protein Synthesis in Obese Adults
Status: Enrolling
Updated: 4/30/2018
Freer Hall
mi
from
Urbana, IL
Click here to add this to my saved trials
Time Restricted Feeding for Weight Loss and Cardio-protection
Time Restricted Feeding for Weight Loss and Cardio-protection
Status: Enrolling
Updated:  4/30/2018
mi
from
Chicago, IL
Time Restricted Feeding for Weight Loss and Cardio-protection
Time Restricted Feeding for Weight Loss and Cardio-protection
Status: Enrolling
Updated: 4/30/2018
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy
Status: Enrolling
Updated:  5/1/2018
mi
from
Cleveland, OH
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy
Status: Enrolling
Updated: 5/1/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials